| Abstrakt: |
Acute Hepatitis, Amides, Antiinfectives, Blood Cells, Digestive System Diseases and Conditions, Drugs and Therapies, Eosinophilia, Eosinophils, Gastroenterology, Gastrointestinal Agents, Granulocytes, Health and Medicine, Hematologic Diseases and Conditions, Hemic and Immune Systems, Hepatitis, Immunology, Infectious Diseases and Conditions, Leukocyte Diseases and Conditions, Leukocyte Disorders, Liver Diseases and Conditions, Pharmaceuticals, Sulfasalazine, Sulfasalazine Therapy, Sulfonamides, 5-aminosalicylates Keywords: 5-aminosalicylates; Acute Hepatitis; Amides; Antiinfectives; Blood Cells; Digestive System Diseases and Conditions; Drugs and Therapies; Eosinophilia; Eosinophils; Gastroenterology; Gastrointestinal Agents; Granulocytes; Health and Medicine; Hematologic Diseases and Conditions; Hemic and Immune Systems; Hepatitis; Immunology; Infectious Diseases and Conditions; Leukocyte Diseases and Conditions; Leukocyte Disorders; Liver Diseases and Conditions; Pharmaceuticals; Sulfasalazine; Sulfasalazine Therapy; Sulfonamides EN 5-aminosalicylates Acute Hepatitis Amides Antiinfectives Blood Cells Digestive System Diseases and Conditions Drugs and Therapies Eosinophilia Eosinophils Gastroenterology Gastrointestinal Agents Granulocytes Health and Medicine Hematologic Diseases and Conditions Hemic and Immune Systems Hepatitis Immunology Infectious Diseases and Conditions Leukocyte Diseases and Conditions Leukocyte Disorders Liver Diseases and Conditions Pharmaceuticals Sulfasalazine Sulfasalazine Therapy Sulfonamides 1804 1804 1 10/24/23 20231023 NES 231023 2023 OCT 27 (NewsRx) -- By a News Reporter-Staff News Editor at Hepatitis Weekly -- New study results on acute hepatitis have been published. [Extracted from the article] |
